Get access to our best features
Get Started
SubscribeLogin
Get access to our best features
Get Started
Published

Klaipėda-based Memel Biotech goes bankrupt after losing major US investor

Summary by Lietuvos Radijas Ir Televizija
Klaipėda-based company Memel Biotech, owned by the US-based biotechnology company Cureline, is going bankrupt. It has encountered financial difficulties and become insolvent, according to a ruling by the Klaipėda District Court, the business news portal Verslo žinios reports on Monday.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Klaipėda

Klaipėda

Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2025 Snapwise Inc
News
For You
Search
BlindspotLocal